Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.67B | 2.69B | 2.63B | 2.59B | 2.36B | 2.12B | Gross Profit |
1.47B | 1.49B | 1.43B | 1.43B | 1.32B | 1.13B | EBIT |
655.51M | 674.00M | 672.76M | 702.36M | 615.13M | 349.55M | EBITDA |
797.34M | 674.00M | 786.74M | 771.62M | 703.55M | 446.95M | Net Income Common Stockholders |
452.36M | 467.28M | 487.49M | 513.10M | 454.37M | 249.54M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
130.42M | 115.95M | 115.68M | 163.46M | 299.97M | 208.29M | Total Assets |
5.87B | 6.00B | 5.25B | 3.82B | 3.79B | 3.67B | Total Debt |
2.30B | 2.32B | 1.86B | 737.86M | 815.90M | 1.11B | Net Debt |
2.16B | 2.20B | 1.75B | 574.40M | 515.92M | 897.70M | Total Liabilities |
2.99B | 3.07B | 2.65B | 1.53B | 1.63B | 1.92B | Stockholders Equity |
2.88B | 814.42M | 2.60B | 2.29B | 2.16B | 1.76B |
Cash Flow | Free Cash Flow | ||||
464.68M | 491.78M | 606.70M | 461.70M | 507.62M | 451.89M | Operating Cash Flow |
542.96M | 556.19M | 641.28M | 513.13M | 545.93M | 502.42M | Investing Cash Flow |
-852.95M | -844.40M | -1.44B | -222.76M | -33.17M | -194.11M | Financing Cash Flow |
307.40M | 294.50M | 750.51M | -416.01M | -422.91M | -251.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $9.18B | 17.90 | 19.60% | 1.16% | 10.59% | 27.04% | |
73 Outperform | $10.06B | 22.50 | 16.15% | 1.71% | 0.78% | -8.42% | |
73 Outperform | $12.74B | 26.87 | 20.22% | 1.37% | -3.75% | -4.27% | |
73 Outperform | $12.99B | 21.04 | 18.45% | 1.19% | -0.53% | 0.13% | |
67 Neutral | $12.28B | 24.42 | 13.77% | 1.70% | -0.16% | -15.42% | |
62 Neutral | $7.24B | 12.39 | 3.08% | 3.39% | 3.63% | -14.35% | |
56 Neutral | $6.56B | 33.61 | 3.11% | 1.42% | -3.47% | ― |
Nordson Corporation reported its fiscal first quarter 2025 results on February 19, 2025, showing a sales decline of 2.8% year-over-year to $615 million, and a decrease in earnings per diluted share to $1.65. Despite weaker sales across multiple end markets, the company saw a 15% growth in backlog and maintained solid operational performance. The company forecasts second-quarter fiscal 2025 sales to range between $650 and $690 million, with adjusted earnings per share expected to be between $2.30 and $2.50, reflecting confidence in overcoming macroeconomic challenges and improving end market demand.